Allianz Asset Management’s 89bio ETNB Stock Holding History

Allianz Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-43,000	Closed	-$632K	–	2017
2025 Q3	$632K	Sell	43,000 -18,000	-30%	-$183K	﹤0.01%	1805
2025 Q2	$599K	Buy	61,000 +48,200	+377%	+$399K	﹤0.01%	1790
2025 Q1	$93.1K	Buy	+12,800	New	+$112K	﹤0.01%	2179

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allianz Asset Management's ETNB Position: Q4 2025 in Review

Allianz Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 43,000 shares — an estimated $632K sold.

Allianz Asset Management first reported a position in ETNB in Q1 2025 and held it in 3 quarters. The position peaked at $632K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Allianz Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Allianz Asset Management sold 43,000 89bio shares in Q4 2025, an estimated $632K.
Allianz Asset Management first reported a position in 89bio in Q1 2025 and held it in 3 quarters.
Allianz Asset Management's 89bio position peaked at $632K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Allianz Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.